Skip to content

KRRO

Korro Bio, Inc.

NASDAQ · USHealthcareBiotechnology
$11.50-6.12%

Price as of Jul 20, 2026

KRRO capital

Korro Bio, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.36x
Net debt / equity
-0.16x
Debt / assets
0.23x
Debt / EBITDA
-0.55x
Net debt / EBITDA
0.24x

Liquidity & coverage

Current ratio
8.13x
Quick ratio
8.13x
Cash ratio
7.71x
Interest coverage
EBITDA / interest
Working capital
$105.4M

Cash & dividend

FCF / debt
-1.65x
Cash flow / debt
-1.64x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.